Tower Research Capital (TRC)’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-744
| Closed | -$15K | – | 6675 |
|
|
2022
Q4 | $15K | Buy |
744
+310
| +71% | +$6.25K | ﹤0.01% | 3473 |
|
|
2022
Q3 | $4K | Sell |
434
-935
| -68% | -$8.62K | ﹤0.01% | 5335 |
|
|
2022
Q2 | $16K | Buy |
1,369
+1,215
| +789% | +$14.2K | ﹤0.01% | 4043 |
|
|
2022
Q1 | $3K | Buy |
+154
| New | +$3K | ﹤0.01% | 5475 |
|
|
2021
Q4 | – | Sell |
-138
| Closed | -$4K | – | 6848 |
|
|
2021
Q3 | $4K | Sell |
138
-120
| -47% | -$3.48K | ﹤0.01% | 5040 |
|
|
2021
Q2 | $3K | Sell |
258
-25
| -9% | -$291 | ﹤0.01% | 4985 |
|
|
2021
Q1 | $3K | Sell |
283
-633
| -69% | -$6.71K | ﹤0.01% | 4952 |
|
|
2020
Q4 | $7K | Buy |
916
+597
| +187% | +$4.56K | ﹤0.01% | 4517 |
|
|
2020
Q3 | $3K | Sell |
319
-3,408
| -91% | -$32.1K | ﹤0.01% | 4542 |
|
|
2020
Q2 | $34K | Buy |
+3,727
| New | +$34K | ﹤0.01% | 3369 |
|